Patients who received a combination of angiotensin-II stimulating and inhibiting antihypertensive drugs did not have significantly different risks of ADRD, but those who received other types of antihypertensive drugs or did not receive antihypertensive drugs for hypertension had significantly higher risks of AD and ADRD. This evidence concerns the gene AGT and Hypertension.